Renhe Pharmacy Co.,Ltd Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	1,011	2,774	2,329	2,615	2,825	2,360
Short-Term Investments	-	-	385.49	155.37	290.03	100
Trading Asset Securities	2,978	1,093	1,017	764.59	416.87	315.6
Cash & Short-Term Investments	3,989	3,867	3,731	3,534	3,532	2,776
Cash Growth	3.93%	3.64%	5.57%	0.06%	27.25%	-3.83%
Accounts Receivable	571.47	271.67	466.59	500.18	477.59	539.8
Other Receivables	12.41	8.92	6.03	8.26	8.82	10.02
Receivables	583.88	280.59	472.62	508.44	486.41	549.82
Inventory	389.18	531.11	486.94	446.58	457.74	601.35
Other Current Assets	197.61	265.6	129.04	94.2	104.33	128.46
Total Current Assets	5,159	4,944	4,820	4,584	4,581	4,056
Property, Plant & Equipment	1,323	1,339	1,423	1,250	1,241	1,112
Long-Term Investments	611.83	602.55	32.4	30.48	536.41	392.69
Goodwill	390.89	390.89	501.91	546.91	578.24	606.12
Other Intangible Assets	290.51	293.96	313.44	420.72	582.87	342.74
Long-Term Deferred Tax Assets	30.65	32.3	32.65	28.25	20.85	6.64
Long-Term Deferred Charges	13.71	14.29	14.59	16.34	22.93	310.64
Other Long-Term Assets	113.69	117.89	345.14	568.04	71.9	81.83
Total Assets	7,934	7,735	7,482	7,445	7,635	6,908
Accounts Payable	195.34	170.79	132.08	123.5	199.62	176.08
Accrued Expenses	18.9	36.39	28.46	33.49	103.52	110.71
Current Portion of Long-Term Debt	0.87	0.89	-	-	-	-
Current Portion of Leases	-	-	0.69	5.79	6.72	2.84
Current Income Taxes Payable	169.56	106.41	72.54	209.63	224.76	211.59
Current Unearned Revenue	126.62	162.52	107.67	124.94	354.56	200.61
Other Current Liabilities	273.26	285.76	294.91	253.67	275.33	266.84
Total Current Liabilities	784.54	762.76	636.35	751.01	1,165	968.66
Long-Term Leases	1.37	1.33	1.89	-	5.79	3.62
Long-Term Unearned Revenue	37.72	38.93	37.96	37.11	38.83	8.25
Long-Term Deferred Tax Liabilities	0.06	0.07	0.11	1.88	3.66	0.28
Other Long-Term Liabilities	0.18	0.18	0.18	0.18	0.18	0.18
Total Liabilities	823.87	803.26	676.48	790.18	1,213	981
Common Stock	1,400	1,400	1,400	1,400	1,400	1,400
Additional Paid-In Capital	752.76	752.76	796.39	810.81	785.76	766.66
Retained Earnings	4,368	4,228	4,044	3,842	3,555	3,121
Treasury Stock	-64.64	-64.64	-66.96	-60.08	-	-
Comprehensive Income & Other	-0.03	-0.01	-	-	-	-
Total Common Equity	6,456	6,316	6,174	5,993	5,741	5,287
Minority Interest	654.14	616.28	632.32	661.46	681	639.65
Shareholders' Equity	7,110	6,932	6,806	6,655	6,422	5,927
Total Liabilities & Equity	7,934	7,735	7,482	7,445	7,635	6,908
Total Debt	2.24	2.22	2.58	5.79	12.52	6.46
Net Cash (Debt)	3,986	3,865	3,729	3,529	3,520	2,770
Net Cash Growth	3.94%	3.65%	5.67%	0.25%	27.09%	-1.86%
Net Cash Per Share	2.84	2.75	2.67	2.52	2.51	2.00
Filing Date Shares Outstanding	1,400	1,417	1,307	1,384	1,400	1,400
Total Common Shares Outstanding	1,400	1,417	1,307	1,391	1,400	1,400
Working Capital	4,375	4,182	4,183	3,833	3,416	3,087
Book Value Per Share	4.61	4.46	4.72	4.31	4.10	3.78
Tangible Book Value	5,775	5,631	5,358	5,025	4,580	4,338
Tangible Book Value Per Share	4.13	3.97	4.10	3.61	3.27	3.10
Buildings	-	-	1,516	1,163	1,001	665.33
Machinery	-	-	548.17	539.32	549.98	513.22
Construction In Progress	-	-	230.72	345.43	409.27	580.58

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.